Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Anavex Life Sciences Corp...

    NASDAQ: AVXL · Real-Time Price · USD
    9.48
    -0.09 (-0.94%)
    At close: Jun 27, 2025, 3:59 PM
    9.25
    -2.43%
    After-hours: Jun 27, 2025, 05:38 PM EDT

    Anavex Life Sciences Statistics

    Share Statistics

    Anavex Life Sciences has 85.37M shares outstanding. The number of shares has increased by 0.5% in one year.

    Shares Outstanding

    n/a
    		 85.37M

    Shares Change (YoY)

    n/a
    		 0.5%

    Shares Change (QoQ)

    n/a
    		 0.29%

    Owned by Institutions (%)

    n/a
    		 34.86%

    Shares Floating

    n/a
    		 82.52M

    Failed to Deliver (FTD) Shares

    n/a
    		 7,139

    FTD / Avg. Volume

    n/a
    		 0.76%

    Short Selling Information

    The latest short interest is 25.03M, so 29.32% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 25.03M

    Short % of Shares Out

    n/a
    		 29.32%

    Short % of Float

    n/a
    		 30.31%

    Short Ratio (days to cover)

    n/a
    		 24.11

    Valuation Ratios

    The PE ratio is -11.03 and the forward PE ratio is 6.67. Anavex Life Sciences's PEG ratio is 0.83.

    PE Ratio

    n/a
    		 -11.03

    Forward PE

    n/a
    		 6.67

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 3.94

    P/FCF Ratio

    n/a
    		 -15.39

    PEG Ratio

    n/a
    		 0.83
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Anavex Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 8.86, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 8.86

    Quick Ratio

    n/a
    		 8.86

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,023,857.14

    Employee Count

    n/a
    		 42

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -2.29M

    Effective Tax Rate

    n/a
    		 5.06%

    Stock Price Statistics

    The stock price has increased by 123.08% in the last 52 weeks. The beta is 0.67, so Anavex Life Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.67

    52-Week Price Change

    n/a
    		 123.08%

    50-Day Moving Average

    n/a
    		 8.53

    200-Day Moving Average

    n/a
    		 8.28

    Relative Strength Index (RSI)

    n/a
    		 67.97

    Average Volume (20 Days)

    n/a
    		 942,759

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -52.88M

    Net Income

    n/a
    		 -43M

    EBITDA

    n/a
    		 -45.29M

    EBIT

    n/a
    		 -45.29M

    Earnings Per Share (EPS)

    n/a
    		 -0.52
    Full Income Statement

    Balance Sheet

    The company has 132.19M in cash and 0 in debt, giving a net cash position of 132.19M.

    Cash & Cash Equivalents

    n/a
    		 132.19M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -336.07M

    Total Assets

    n/a
    		 117.14M

    Working Capital

    n/a
    		 107.94M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -30.81M and capital expenditures 0, giving a free cash flow of -30.81M.

    Operating Cash Flow

    n/a
    		 -30.81M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -30.81M

    FCF Per Share

    n/a
    		 -0.37
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    AVXL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AVXL is $46, which is 380.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $46

    Price Target Difference

    n/a
    		 380.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 7, 2015. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Oct 7, 2015

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 18.36

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist